Indication
Migraine - prevention
RAG rating
Double Red
Document type
NICE technology appraisal
Place
Hertfordshire and West Essex ICB
Output type
Pharmacy / Prescribing

Atogepant

NICE TA 973 Atogepant for preventing migraine was published on 15 May 2024.

Implementation of this NICE TA is being considered by system partners within Hertfordshire and West Essex ICS. In line with accepted and required governance processes for local decision making, any guidelines will require review and approval by Hertfordshire and West Essex Area Prescribing Committee and ratification by Hertfordshire and West Essex ICB Commissioning Committee.

In the interim, clinicians are advised to continue to follow existing local guidelines.

 

Any update to local guidelines will be published on the Hertfordshire and West Essex ICB Prescribing, Policies and Pathways website at https://www.hweclinicalguidance.nhs.uk/home

 


Back